These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 23688984)
1. [Changes in gene expression profiles in multiple myeloma cells after knocking-down SNF5, a core subunit of SWI/SNF complex]. Xie Y; Xu Y Nan Fang Yi Ke Da Xue Xue Bao; 2013 May; 33(5):667-71. PubMed ID: 23688984 [TBL] [Abstract][Full Text] [Related]
2. The SWI/SNF chromatin-remodeling complex subunit SNF5 is essential for hepatocyte differentiation. Gresh L; Bourachot B; Reimann A; Guigas B; Fiette L; Garbay S; Muchardt C; Hue L; Pontoglio M; Yaniv M; Klochendler-Yeivin A EMBO J; 2005 Sep; 24(18):3313-24. PubMed ID: 16138077 [TBL] [Abstract][Full Text] [Related]
3. Increased DNA damage sensitivity and apoptosis in cells lacking the Snf5/Ini1 subunit of the SWI/SNF chromatin remodeling complex. Klochendler-Yeivin A; Picarsky E; Yaniv M Mol Cell Biol; 2006 Apr; 26(7):2661-74. PubMed ID: 16537910 [TBL] [Abstract][Full Text] [Related]
4. Multiple interactions of the oncoprotein transcription factor MYC with the SWI/SNF chromatin remodeler. Woodley CM; Romer AS; Wang J; Guarnaccia AD; Elion DL; Maxwell JN; Guerrazzi K; McCann TS; Popay TM; Matlock BK; Flaherty DK; Lorey SL; Liu Q; Tansey WP; Weissmiller AM Oncogene; 2021 May; 40(20):3593-3609. PubMed ID: 33931740 [TBL] [Abstract][Full Text] [Related]
5. Cellular senescence regulated by SWI/SNF complex subunits through p53/p21 and p16/pRB pathway. He L; Chen Y; Feng J; Sun W; Li S; Ou M; Tang L Int J Biochem Cell Biol; 2017 Sep; 90():29-37. PubMed ID: 28716547 [TBL] [Abstract][Full Text] [Related]
6. Loss of SNF5 expression correlates with poor patient survival in melanoma. Lin H; Wong RP; Martinka M; Li G Clin Cancer Res; 2009 Oct; 15(20):6404-11. PubMed ID: 19808872 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors. McKenna ES; Tamayo P; Cho YJ; Tillman EJ; Mora-Blanco EL; Sansam CG; Koellhoffer EC; Pomeroy SL; Roberts CW Cell Cycle; 2012 May; 11(10):1956-65. PubMed ID: 22544318 [TBL] [Abstract][Full Text] [Related]
8. SNF5/INI1 deficiency redefines chromatin remodeling complex composition during tumor development. Wei D; Goldfarb D; Song S; Cannon C; Yan F; Sakellariou-Thompson D; Emanuele M; Major MB; Weissman BE; Kuwahara Y Mol Cancer Res; 2014 Nov; 12(11):1574-85. PubMed ID: 25009291 [TBL] [Abstract][Full Text] [Related]
9. SNF5, a core component of the SWI/SNF complex, is necessary for p53 expression and cell survival, in part through eIF4E. Xu Y; Yan W; Chen X Oncogene; 2010 Jul; 29(28):4090-100. PubMed ID: 20473326 [TBL] [Abstract][Full Text] [Related]
10. The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors. Caramel J; Medjkane S; Quignon F; Delattre O Oncogene; 2008 Mar; 27(14):2035-44. PubMed ID: 17922027 [TBL] [Abstract][Full Text] [Related]
11. Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation. Isakoff MS; Sansam CG; Tamayo P; Subramanian A; Evans JA; Fillmore CM; Wang X; Biegel JA; Pomeroy SL; Mesirov JP; Roberts CW Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17745-50. PubMed ID: 16301525 [TBL] [Abstract][Full Text] [Related]
12. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival. Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802 [TBL] [Abstract][Full Text] [Related]
13. [Effect of PIH1D1 on the degradation of its binding protein SNF5]. Zhai N; Zhang Y; Shen YF Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Dec; 31(6):756-9. PubMed ID: 20078948 [TBL] [Abstract][Full Text] [Related]
14. Linking the SWI/SNF complex to prostate cancer. Lee RS; Roberts CW Nat Genet; 2013 Nov; 45(11):1268-9. PubMed ID: 24165726 [TBL] [Abstract][Full Text] [Related]
15. Activation of β-catenin/TCF targets following loss of the tumor suppressor SNF5. Mora-Blanco EL; Mishina Y; Tillman EJ; Cho YJ; Thom CS; Pomeroy SL; Shao W; Roberts CW Oncogene; 2014 Feb; 33(7):933-8. PubMed ID: 23435428 [TBL] [Abstract][Full Text] [Related]
16. The functional role of the CARM1-SNF5 complex and its associated HMT activity in transcriptional activation by thyroid hormone receptor. Choi HK; Choi KC; Oh SY; Kang HB; Lee YH; Haam S; Ahn YH; Kim KS; Kim K; Yoon HG Exp Mol Med; 2007 Aug; 39(4):544-55. PubMed ID: 17934343 [TBL] [Abstract][Full Text] [Related]
17. Wongabel rhabdovirus accessory protein U3 targets the SWI/SNF chromatin remodeling complex. Joubert DA; Rodriguez-Andres J; Monaghan P; Cummins M; McKinstry WJ; Paradkar PN; Moseley GW; Walker PJ J Virol; 2015 Jan; 89(2):1377-88. PubMed ID: 25392228 [TBL] [Abstract][Full Text] [Related]
18. Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis. Darr J; Klochendler A; Isaac S; Eden A Oncogene; 2014 Jun; 33(23):3024-32. PubMed ID: 23851500 [TBL] [Abstract][Full Text] [Related]
19. Epigenetics and cancer: altered chromatin remodeling via Snf5 loss leads to aberrant cell cycle regulation. Sansam CG; Roberts CW Cell Cycle; 2006 Mar; 5(6):621-4. PubMed ID: 16582616 [TBL] [Abstract][Full Text] [Related]
20. Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5. Roberts CW; Leroux MM; Fleming MD; Orkin SH Cancer Cell; 2002 Nov; 2(5):415-25. PubMed ID: 12450796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]